Healthcare provider profile · identity verified

Joseph C King

Family Practice · SPRINGBORO, OH · NPI 1770046872

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	496	173
Levothyroxine Sodium	Levothyroxine Sodium	348	106
Lisinopril	Lisinopril	262	84
Amlodipine Besylate	Amlodipine Besylate	229	80
Omeprazole	Omeprazole	184	67
Pantoprazole Sodium	Pantoprazole Sodium	137	47
Losartan Potassium	Losartan Potassium	136	45
Rosuvastatin Calcium	Rosuvastatin Calcium	130	49
Gabapentin	Gabapentin	111	49
Furosemide	Furosemide	110	44
Metoprolol Succinate	Metoprolol Succinate	110	39
Tamsulosin Hcl	Tamsulosin Hcl	110	39
Escitalopram Oxalate	Escitalopram Oxalate	108	31
Tramadol Hcl	Tramadol Hcl	104	29
Famotidine	Famotidine	102	37
Trazodone Hcl	Trazodone Hcl	102	39
Metformin Hcl Er	Metformin Hcl	97	34
Metformin Hcl	Metformin Hcl	96	30
Sertraline Hcl	Sertraline Hcl	88	30
Meloxicam	Meloxicam	87	22
Albuterol Sulfate Hfa	Albuterol Sulfate	74	36
Glimepiride	Glimepiride	74	23
Pravastatin Sodium	Pravastatin Sodium	74	25
Methylprednisolone	Methylprednisolone	72	63
Tizanidine Hcl	Tizanidine Hcl	67	25
Montelukast Sodium	Montelukast Sodium	65	22
Synthroid	Levothyroxine Sodium	65	17
Hydrochlorothiazide	Hydrochlorothiazide	61	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	21
Donepezil Hcl	Donepezil Hcl	56	14
Valsartan	Valsartan	53	13
Fluticasone Propionate	Fluticasone Propionate	52	22
Naproxen	Naproxen	52	37
Finasteride	Finasteride	51	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	14
Buspirone Hcl	Buspirone Hcl	50	16
Carvedilol	Carvedilol	50	18
Duloxetine Hcl	Duloxetine Hcl	50	17
Simvastatin	Simvastatin	49	15
Pioglitazone Hcl	Pioglitazone Hcl	48	11
Cephalexin	Cephalexin	47	33
Alendronate Sodium	Alendronate Sodium	44	18
Metoprolol Tartrate	Metoprolol Tartrate	44	15
Oxybutynin Chloride Er	Oxybutynin Chloride	44	15
Citalopram Hbr	Citalopram Hydrobromide	43	13
Eliquis	Apixaban	43	18
Jardiance	Empagliflozin	42	12
Clonazepam	Clonazepam	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	33
Prednisone	Prednisone	37	28
Allopurinol	Allopurinol	36	14
Mounjaro	Tirzepatide	36	suppressed
Azithromycin	Azithromycin	35	33
Spironolactone	Spironolactone	35	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	15
Januvia	Sitagliptin Phosphate	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Alprazolam	Alprazolam	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	25
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Potassium Chloride	Potassium Chloride	29	11
Bupropion Xl	Bupropion Hcl	28	suppressed
Carisoprodol	Carisoprodol	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Ezetimibe	Ezetimibe	27	12
Lorazepam	Lorazepam	27	11
Pregabalin	Pregabalin	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Bumetanide	Bumetanide	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Klor-Con M20	Potassium Chloride	23	suppressed
Diazepam	Diazepam	22	suppressed
Ondansetron Odt	Ondansetron	22	13
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	18
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Promethazine Hcl	Promethazine Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Ibuprofen	Ibuprofen	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Baclofen	Baclofen	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Methocarbamol	Methocarbamol	15	11
Mirtazapine	Mirtazapine	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Primidone	Primidone	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Ozempic	Semaglutide	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Carbatrol	Carbamazepine	11	suppressed
Estradiol	Estradiol	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error